Board of Directors
John Haurum, MD DPhil
Chairman
Non-executive Director in several European biotech companies: Agomab, CatalYm, Neophore, Storm, Synact, Synklino
Jeroen Bakker, PhD
Novo Seeds
Principal at Novo Holdings and part of the Novo Seeds team focusing on company creation and early-stage financings
Joël Jean-Mairet, PhD
Ysios Capital
Managing partner and co-founder of Ysios Capital. Co-founded Glycart Biotechnology in 2001
Carl Kilander, MD PhD
HealthCap
Partner at HealthCap. Carl co-founded and was CEO of a health-tech start-up exited in 2019. Carl is a Medical Doctor trained at the Karolinska Institute and at Harvard Medical School
Sanne de Jongh, MSc
Gilde Healthcare
Investment Manager at Gilde Healthcare, where she focuses on the firms’ investment activities in the biopharmaceutical sector
Rez Halse, PhD
RA Capital
President, RA Ventures at RA Capital Management. Rez’s primary responsibility is to lead early-stage private investments in companies developing drugs
Lars H. Engelholm, PhD
Founder representative